Literature DB >> 27165663

The effectiveness of i.v. cefuroxime prophylaxis of surgical site infection after elective inguinal hernia repair with mesh: A retrospective observational study.

Yeye Zhuo1, Qian Zhang2, Danling Tang2, De Cai2.   

Abstract

PURPOSE: The efficacy of routine antibiotic prophylaxis for prevention of surgical site infection (SSI) after elective inguinal hernia repair with a mesh patch remains uncertain. The authors of a recent Cochrane meta-analysis based on 17 randomized trials were unable to draw a definitive conclusion on this subject. The purpose of this study was to determine the effectiveness of prophylactic antibiotics for prevention of SSI after elective inguinal hernia repair with mesh and the risk factors for SSI.
METHODS: All low-risk patients who underwent elective inguinal hernia repair with mesh at our institution between 2010 and 2015 were enrolled in this study, with the exception of patients with recurrent hernias or immunosuppressive diseases. All patients received a single intravenous (i.v.) injection of cefuroxime (1.5 g) within 2 h prior to surgery at the discretion of the surgeon. SSI was defined using criteria of the Centers for Disease Control and Prevention. The variables which could influence the rate of SSI were analyzed by multivariate analysis to determine the independent risk factors for SSI.
RESULTS: Among the 605 patients who underwent elective inguinal hernia repair with mesh during the study period, 553 were eligible for enrolment in the study. Of these, 331 received a single dose of cefuroxime preoperatively. The overall SSI rate was 5.4 %; 9.4 % of those patients who did not receive preoperative antibiotic prophylaxis developed SSI versus 2.8 % of those who did receive prophylaxis (P = 0.001). All infections were superficial. Factors independently associated with SSI were advanced age, smoking and preoperative stay.
CONCLUSIONS: The incidence of SSI among low-risk patients who did and did not receive preoperative antibiotic prophylaxis after elective inguinal hernia repair with mesh differed significantly, particularly among patients of advanced age, smokers and patients with a prolonged preoperative stay in the hospital.

Entities:  

Keywords:  CDC criteria; Elective inguinal hernia repair with mesh; Preoperative antibiotic prophylaxis; Surgical site infection

Mesh:

Substances:

Year:  2016        PMID: 27165663     DOI: 10.1007/s00228-016-2067-4

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  35 in total

1.  CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections.

Authors:  T C Horan; R P Gaynes; W J Martone; W R Jarvis; T G Emori
Journal:  Am J Infect Control       Date:  1992-10       Impact factor: 2.918

2.  Relationship between age and the risk of surgical site infection: a contemporary reexamination of a classic risk factor.

Authors:  Thomas R Talbot; William Schaffner
Journal:  J Infect Dis       Date:  2005-02-24       Impact factor: 5.226

Review 3.  Current guidelines for antibiotic prophylaxis of surgical wounds.

Authors:  R K Woods; E P Dellinger
Journal:  Am Fam Physician       Date:  1998-06       Impact factor: 3.292

4.  The tension-free hernioplasty.

Authors:  I L Lichtenstein; A G Shulman; P K Amid; M M Montllor
Journal:  Am J Surg       Date:  1989-02       Impact factor: 2.565

Review 5.  Systematic review and meta-analysis of the effectiveness of antibiotic prophylaxis in prevention of wound infection after mesh repair of abdominal wall hernia.

Authors:  T J Aufenacker; M J W Koelemay; D J Gouma; M P Simons
Journal:  Br J Surg       Date:  2006-01       Impact factor: 6.939

6.  Quality assessment of 26,304 herniorrhaphies in Denmark: a prospective nationwide study.

Authors:  M Bay-Nielsen; H Kehlet; L Strand; J Malmstrøm; F H Andersen; P Wara; P Juul; T Callesen
Journal:  Lancet       Date:  2001-10-06       Impact factor: 79.321

7.  A randomized, double-blind, placebo-controlled trial to determine effectiveness of antibiotic prophylaxis for tension-free mesh herniorrhaphy.

Authors:  Anthony R Perez; Manuel F Roxas; Serafin S Hilvano
Journal:  J Am Coll Surg       Date:  2005-03       Impact factor: 6.113

8.  Long-term follow-up of a randomized controlled trial of suture versus mesh repair of incisional hernia.

Authors:  Jacobus W A Burger; Roland W Luijendijk; Wim C J Hop; Jens A Halm; Emiel G G Verdaasdonk; Johannes Jeekel
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

9.  The role of antibiotic prophylaxis in mesh repair of primary inguinal hernias using prolene hernia system: a randomized prospective double-blind control trial.

Authors:  S K Jain; M Jayant; C Norbu
Journal:  Trop Doct       Date:  2008-04       Impact factor: 0.731

10.  European Hernia Society guidelines on the treatment of inguinal hernia in adult patients.

Authors:  M P Simons; T Aufenacker; M Bay-Nielsen; J L Bouillot; G Campanelli; J Conze; D de Lange; R Fortelny; T Heikkinen; A Kingsnorth; J Kukleta; S Morales-Conde; P Nordin; V Schumpelick; S Smedberg; M Smietanski; G Weber; M Miserez
Journal:  Hernia       Date:  2009-07-28       Impact factor: 4.739

View more
  1 in total

1.  Pre-surgical peripheral blood inflammation markers predict surgical site infection following mesh repair of groin hernia.

Authors:  Yeye Zhuo; Juntian Chen; Qian Zhang; Xinxin Li
Journal:  Medicine (Baltimore)       Date:  2021-03-05       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.